Malmbergs Elektriska AB (publ) (LON:0JCX)
46.50
-0.40 (-0.85%)
At close: Apr 22, 2025
Revance Therapeutics Market Cap
Malmbergs Elektriska AB has a market cap or net worth of 26.17 million as of August 1, 2025. Its market cap has decreased by -0.32% in one year.
Market Cap
26.17M
Enterprise Value
29.78M
Revenue
38.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
$46.50
Market Cap Chart
Since March 16, 1999, Malmbergs Elektriska AB's market cap has increased from 12.45M to 26.17M, an increase of 110.20%. That is a compound annual growth rate of 2.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 26.19M | 6.72% |
Dec 30, 2024 | 24.54M | -14.88% |
Dec 29, 2023 | 28.83M | -4.50% |
Dec 30, 2022 | 30.19M | -28.90% |
Dec 30, 2021 | 42.46M | 1.96% |
Dec 30, 2020 | 41.65M | 2.81% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.60B |
HSBC Holdings | 160.06B |
Shell | 159.31B |
Unilever | 109.82B |
Rolls-Royce Holdings | 89.38B |
British American Tobacco p.l.c. | 88.30B |
Rio Tinto Group | 76.62B |
RELX PLC | 72.00B |